Essex Bio-Technology

Essex Bio-Technology, a bio-pharmaceutical company that develops, manufactures and commercialises genetically engineered therapeutic Fibroblast Growth Factors (FGFs), having six flagship biologics approved for use in ophthalmology, dermatology and wound healing since 1998. Our products are available in more than hospitals through our direct sales, marketing and distribution centres in Asia. Further, we maintain a pipeline of research programmes in various clinical stages, covering a wide range of fields and indications. With 4 research sites globally, the company leverages on its in-house R&D expertise and platform in growth factors (i.e. FGF2) and antibodies to maintain a pipeline of research projects in various clinical stages, covering a wide range of fields and indications.